miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer

per Guo, Xiaofeng, Zhu, Yuekun, Hong, Xinya, Zhang, Mukun, Qiu, Xingfeng, Wang, Zhenfa, Qi, Zhongquan, Hong, Xuehui
Publicat a Cell Death Dis (2017)